D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical Programs
SHANGHAI, Dec. 10, 2025 /PRNewswire/ -- D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round. The...
VINSSEN and ILDO F&C Form Exclusive Alliance to Advance Composite Bipolar Plate Technology for Hydrogen Systems
Joint innovation targets lower costs, higher durability, and broader applications across the hydrogen value chain SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- VINSSEN, a maritime decarbonization technology company specializing in hydrogen fuel...
Convergen Secures $10 Million Seed Funding to Advance TrimTAC Platform for Neurodegeneration & beyond
SUZHOU, China, Dec. 8, 2025 /PRNewswire/ -- Convergen, a biotech company pioneering targeted protein degradation (TPD) therapies for diseases driven by pathological protein aggregates, today announced the closing of a $10 million Seed financing...
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025
– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement – – Strong activity observed across ESA-refractory and ESA-intolerant patients, and across mutation and morphology subtypes – – Favorable safety...
PT Fapon and PT Bio Farma Forge Strategic Partnership to Advance IVD Localization and Innovation in Indonesia
DONGGUAN, China, Dec. 8, 2025 /PRNewswire/ -- PT Fapon Bioindustries Indonesia (referred to as "PT Fapon") and the Indonesian state-owned pharmaceutical holding company PT Bio Farma (Persero) (referred to as "Bio Farma") officially signed a...
Geleximco Group and China intelligent chassis solution provider Leekr Technology signed a MoU to deepen industrial collaboration
SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- Geleximco Group and Leekr Technology, a leading Chinese provider of intelligent chassis system solutions, formally signed a Memorandum of Understanding (MoU) in Shanghai. By combining their respective...
IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 8, 2025 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel cell...
Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Advancing Strategic Advisory Capabilities for Corporate Clients NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Newmark Group, Inc. (Nasdaq: NMRK) ("Newmark" or "the Company"), a leading commercial real estate advisor and service provider to large...
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
Companies to advance CR-001, a PD-1 x VEGF bispecific antibody, and SKB105, an integrin beta-6-directed antibody-drug conjugate (ADC), in global markets and China Collaboration designed to accelerate and expand the development of synergistic...
UNESCO and Walnut Coding join forces to advance digital education
Partnership aims to bridge the digital divide and equip youth with future-ready skills BEIJING, Dec. 4, 2025 /PRNewswire/ -- UNESCO has signed a partnership agreement with Walnut Coding, a leading digital education platform for young learners, to...